Neurology Department, Strasbourg University Hospital, Strasbourg, France.
Strasbourg Federation of Translational Medicine (FMTS), Strasbourg University, Strasbourg, France.
J Neurol. 2022 Dec;269(12):6354-6365. doi: 10.1007/s00415-022-11253-1. Epub 2022 Jul 23.
Despite recent progress in the field of genetics, sporadic late-onset (> 40 years) cerebellar ataxia (SLOCA) etiology remains frequently elusive, while the optimal diagnostic workup still needs to be determined. We aimed to comprehensively describe the causes of SLOCA and to discuss the relevance of the investigations.
We included 205 consecutive patients with SLOCA seen in our referral center. Patients were prospectively investigated using exhaustive clinical assessment, biochemical, genetic, electrophysiological, and imaging explorations.
We established a diagnosis in 135 (66%) patients and reported 26 different causes for SLOCA, the most frequent being multiple system atrophy cerebellar type (MSA-C) (41%). Fifty-one patients (25%) had various causes of SLOCA including immune-mediated diseases such as multiple sclerosis or anti-GAD antibody-mediated ataxia; and other causes, such as alcoholic cerebellar degeneration, superficial siderosis, or Creutzfeldt-Jakob disease. We also identified 11 genetic causes in 20 patients, including SPG7 (n = 4), RFC1-associated CANVAS (n = 3), SLC20A2 (n = 3), very-late-onset Friedreich's ataxia (n = 2), FXTAS (n = 2), SCA3 (n = 1), SCA17 (n = 1), DRPLA (n = 1), MYORG (n = 1), MELAS (n = 1), and a mitochondriopathy (n = 1) that were less severe than MSA-C (p < 0.001). Remaining patients (34%) had idiopathic late-onset cerebellar ataxia which was less severe than MSA-C (p < 0.01).
Our prospective study provides an exhaustive picture of the etiology of SLOCA and clues regarding yield of investigations and diagnostic workup. Based on our observations, we established a diagnostic algorithm for SLOCA.
尽管遗传学领域取得了近期进展,但散发性晚发性(> 40 岁)小脑共济失调(SLOCA)的病因仍时常难以确定,而最佳诊断方法仍有待确定。我们旨在全面描述 SLOCA 的病因,并讨论检查的相关性。
我们纳入了在我们的转诊中心就诊的 205 例连续 SLOCA 患者。对患者进行了全面的临床评估、生化、遗传、电生理和影像学检查。
我们在 135 例(66%)患者中确立了诊断,并报告了 26 种不同的 SLOCA 病因,最常见的是多系统萎缩小脑型(MSA-C)(41%)。51 例(25%)患者有多种病因的 SLOCA,包括多发性硬化症或抗 GAD 抗体介导的共济失调等免疫介导性疾病,以及酒精性小脑变性、脑表面铁沉积症或克雅氏病等其他病因。我们还在 20 例患者中发现了 11 种遗传病因,包括 SPG7(n = 4)、RFC1 相关 CANVAS(n = 3)、SLC20A2(n = 3)、极晚发性弗里德里希共济失调(n = 2)、FXTAS(n = 2)、SCA3(n = 1)、SCA17(n = 1)、DRPLA(n = 1)、MYORG(n = 1)、MELAS(n = 1)和 1 种线粒体病(n = 1),其严重程度均低于 MSA-C(p < 0.001)。其余 34%的患者(n = 71)为特发性晚发性小脑共济失调,其严重程度低于 MSA-C(p < 0.01)。
我们的前瞻性研究提供了 SLOCA 病因的详尽描述,并为检查结果和诊断方法提供了线索。基于我们的观察,我们为 SLOCA 建立了一个诊断算法。